BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21418858)

  • 1. [Killing effects of controllable expression of tumor necrosis factor-related apoptosis-inducing ligand from mesenchymal stem cells on hepatocellular carcinoma cells].
    Liu Z; Ma H; Shi J; Zhang YX; Liu YX; Zheng DX
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(8):544-8. PubMed ID: 21418858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells.
    Jacob D; Schumacher G; Bahra M; Davis J; Zhu HB; Zhang LD; Teraishi F; Neuhaus P; Fang BL
    World J Gastroenterol; 2005 May; 11(17):2552-6. PubMed ID: 15849810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
    He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
    Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NCI-N87.
    Wei XC; Wang XJ; Chen K; Zhang L; Liang Y; Lin XL
    World J Gastroenterol; 2001 Aug; 7(4):559-62. PubMed ID: 11819829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
    Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of TRAIL(114-281) mediated by adeno-associated virus and its tumoricidal activity].
    Ma H; Liu YX; Liu SL; Xu RA; Zheng DX
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1635-41. PubMed ID: 15569460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
    Zhu RX; Lin JS; Song YH; Li PY; Tao LW
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF; Cao JG; Tian L; Liu F
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5.
    Zhang B; Shan H; Li D; Li ZR; Zhu KS; Jiang ZB; Huang MS
    Oncol Rep; 2011 Feb; 25(2):461-8. PubMed ID: 21152876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.
    Moniri MR; Sun XY; Rayat J; Dai D; Ao Z; He Z; Verchere CB; Dai LJ; Warnock GL
    Cancer Gene Ther; 2012 Sep; 19(9):652-8. PubMed ID: 22767216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice.
    Zheng L; Weilun Z; Minghong J; Yaxi Z; Shilian L; Yanxin L; Dexian Z
    BMC Cancer; 2012 Apr; 12():153. PubMed ID: 22530952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells with adenovirus-mediated TRAIL gene transduction have antitumor effects on esophageal cancer cell line Eca-109.
    Li L; Li F; Tian H; Yue W; Li S; Chen G
    Acta Biochim Biophys Sin (Shanghai); 2014 Jun; 46(6):471-6. PubMed ID: 24739635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.
    Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F
    Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.